Immune Engager Therapies Demonstrate Promise Following Relapse on Ide-Cel in Multiple Myeloma

Treatment with immune engager therapies following relapse on ide-cel resulted in better median PFS vs other therapies for patients with multiple myeloma.

Related Keywords

Murali Janakiram , ,Cellular Therapy Meetings ,2024 Transplantation Amp Cellular Therapy Meetings ,Immune Engager Therapies ,Diets ,Progression Free Survival ,Mmm ,Multiple Myeloma ,Idecabtagene Vicleucel ,Ide Cel ,Abecma ,